Serylleucine (L-ser-L-leu) is a dipeptide. Serylleucine's core 1 o-glycosylated peptide (SLC1G) can be detected in urine as a metabolite and is a biomarker in TB studies[1].
Definition
ChEBI: Ser-Leu is a dipeptide formed from L-serine and L-leucine residues. It has a role as a metabolite.